Management

BFIS in general respond to a broad spectrum of antiseizure medication. Since most cases do not development an epilepsy in adulthood, medication can be stopped after a 6-12 months seizure free-period. Approximately 40% of BFIS patient also develop PKD later in life. Therapy strategy include avoidance of trigger factors such specific voluntary movements but also a broad spectrum of antiseizure medications are effective especially sodium channel blockers.